On Feb. 15, the U.S. Food and Drug Administration (FDA) will decide whether to authorize Pfizer’s COVID shot for infants and toddlers.
In a “deeply disturbing” speech last week, President Biden exhorted medical coercion of an experimental gene therapy for a virus with a 99% survival rate.